ArticleScientific reports2020

A novel anti-HER2 antibody GB235 reverses Trastuzumab resistance in HER2-expressing tumor cells in vitro and in vivo.

Mengjun Shu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.